ArticleCureus2025
Human Herpesvirus 6 Associated With a Secondary Central Nervous System Vasculitis in an Immunocompetent Adult: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A telomere-lipid-immunity axis linking viral integration to autoimmune disease risk.GeroScience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human herpesvirus 6 (HHV-6) encephalitis typically affects children under three years of age, and adult cases are rare, usually occurring in immunocompromised individuals such as hematopoietic stem cell transplant recipients. HHV-6 can establish latency and reactivate under conditions of immunosuppression. Several neurotropic viruses, including varicella-zoster virus and herpes simplex virus, are known to induce central nervous system (CNS) vasculitis, but HHV-6 has not been clearly associated with this complication. We report the case of a 46-year-old immunocompetent woman presenting with encephalopathy, hemiparesis, and cerebellar signs. Brain MRI revealed ischemic lesions in multiple vascular territories and imaging features suggestive of cerebral vasculitis. Cerebrospinal fluid polymerase chain reaction (CSF PCR) was positive for HHV-6. Other etiologies, including neoplastic and autoimmune causes, were ruled out. The patient was treated with ganciclovir and dexamethasone at doses appropriate for CNS vasculitis. This case highlights a rare presentation of HHV-6-associated CNS vasculitis in an immunocompetent host and emphasizes the need to consider viral etiologies in the differential diagnosis of CNS vasculopathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.